# CLVS2

## Overview
CLVS2, or clavesin 2, is a gene that encodes a neuron-specific protein involved in intracellular vesicle trafficking, particularly within the nervous system. The protein clavesin 2 is categorized as a lipid- and clathrin-binding protein, playing a crucial role in maintaining endosomal and lysosomal morphology, which is essential for synaptic function and neuronal communication. This protein is primarily localized to the cell membrane, some nuclei, and the cytoplasm, where it modulates intracellular trafficking pathways vital for cognitive and neurological processes (Pan2022Bioinformatics). The proper functioning of clavesin 2 is significant for maintaining the integrity of neuronal communication pathways, impacting overall neurological health and potentially linking to various neurological disorders (Pan2022Bioinformatics).

## Structure


## Function
CLVS2, or clavesin 2, is a gene that encodes a protein involved in intracellular vesicle trafficking, particularly within the nervous system. The clavesin 2 protein is associated with endosomal membranes and plays a critical role in maintaining endosomal morphology and function. This protein is crucial for proper synaptic function and neuronal communication, impacting cognitive and neurological processes. In healthy human cells, clavesin 2 is a neuron-specific lipid- and clathrin-binding protein that regulates lysosomal morphology, which is essential for the maintenance of cellular homeostasis and the proper functioning of neuronal cells (Pan2022Bioinformatics).

The protein's activity is primarily localized to the cell membrane, some nuclei, and the cytoplasm, where it contributes to the regulation of endosomal and lysosomal structures. This localization is significant for its role in modulating intracellular trafficking pathways, which are vital for synaptic transmission and neuronal signaling (Pan2022Bioinformatics). The proper functioning of clavesin 2 is essential for maintaining the integrity of neuronal communication pathways, which are fundamental for cognitive functions and overall neurological health.

## Clinical Significance
CLVS2 (clavesin 2) has been implicated in prostate cancer as part of a prognostic biomarker axis involving MEG3, hsa-miR-222-3p, and NRG1. Alterations in the expression of CLVS2, particularly its down-regulation, have been associated with prostate cancer progression. The expression of CLVS2 is regulated by methylation, with higher methylation levels observed in prostate cancer tissues compared to normal tissues, suggesting that methylation modifications may play a role in its dysregulation (Pan2022Bioinformatics; Pan2023PTENrelated). 

CLVS2 is also linked to immune cell infiltration in the tumor microenvironment, which may influence cancer development and progression (Pan2022Bioinformatics; Pan2023PTENrelated). The protein expression of CLVS2 is localized in the cell membrane, nuclei, and cytoplasm, and its expression is part of the MEG3-miR-222-3p-NRG1/CLVS2 axis, which is significant in prostate cancer prognosis (Pan2023PTENrelated). 

While the role of CLVS2 in other diseases or conditions is not extensively detailed in the provided context, its involvement in vesicle trafficking and membrane dynamics suggests potential links to neurological disorders, although specific conditions are not mentioned in the context (Pan2022Bioinformatics).

## Interactions



## References


1. (Pan2022Bioinformatics) Bioinformatics Analysis to Identify MEG3-hsa-miR-222-3p-NRG1/CLVS2 Axis as a Prognostic Biomarker in Prostate Cancer. This article has 0 citations.

2. (Pan2023PTENrelated) PTEN-related ceRNA (MEG3-hsa-miR-222-3p-NRG1/CLVS2) axis as a prognostic biomarker in prostate cancer. This article has 0 citations.